Last reviewed · How we verify

NCT05329675: TSLC

Trial of Sinphar Lipucan Capsule to Regulate Immune Function

Status unknown NA Last updated 17 November 2022
What this trial tests

NA trial testing Sinphar Lipucan Capsule in Nutrition, Healthy in 108 participants. Status unknown.

Timeline
1 April 2022
Primary endpoint
30 April 2024
30 April 2025

Quick facts

Lead sponsorTaipei Medical University WanFang Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment108
Start date1 April 2022
Primary completion30 April 2024
Estimated completion30 April 2025
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Taipei Medical University WanFang Hospital

Who can join

Adults 20 to 65, any sex, with Nutrition, Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Trial of Sinphar Lipucan Capsule to regulate immune function

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Nutrition, Healthy

Currently open trials in the same condition.

Other Taipei Medical University WanFang Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05329675.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing